New Triple-Threat attack on advanced ovarian cancer
NCT ID NCT05952453
Summary
This study is testing a multi-step treatment plan for people newly diagnosed with advanced ovarian cancer. It combines standard chemotherapy with an immunotherapy drug before surgery, followed by a targeted therapy pill and immunotherapy as long-term maintenance. The main goal is to see if this approach can keep the cancer from growing back for a longer period of time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
O'Neal Comprehensive Cancer Center at UAB
RECRUITINGBirmingham, Alabama, 35294, United States
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.